{"id":1211000,"date":"2020-10-16T11:36:27","date_gmt":"2020-10-16T09:36:27","guid":{"rendered":"https:\/\/staging.laboklin.com\/int\/en\/hund"},"modified":"2022-08-16T14:27:41","modified_gmt":"2022-08-16T12:27:41","slug":"dog","status":"publish","type":"page","link":"https:\/\/laboklin.com\/en\/products\/genetics\/hereditary-diseases\/dog\/","title":{"rendered":"Dog"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]For some breeds, we also offer breed-specific genetic test combinations<\/a> to test for several hereditary diseases.[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=”vc_default” css=”.vc_custom_1612193220488{margin-top: 30px !important;}”][vc_column][vc_column_text]

Diagnostic spectrum<\/h3>
  • Acatalasemia<\/a><\/li>
  • Achromatopsia (day blindness) (ACHM)<\/a><\/li>
  • Acral mutilation syndrome (AMS)<\/a><\/li>
  • Acute respiratory distress syndrome (ARDS)<\/a><\/li>
  • Adult onset neuropathy* (AON)<\/a><\/li>
  • Afibrinogenemia* (AFG)<\/a><\/li>
  • Alaskan Husky encephalopathy (AHE)<\/a><\/li>
  • Alaskan Malamute polyneuropathy (AMPN)<\/a><\/li>
  • Alexander disease (AxD)<\/a><\/li>
  • Amelogenesis imperfecta \/ Familial enamel hypoplasia (AI\/FEH)<\/a><\/li>
  • Behaviour propensity<\/a><\/li>
  • Brachyuria (stumpy tail)<\/a><\/li>
  • C3 deficiency (C3)<\/a><\/li>
  • Canine leucocyte adhesion deficiency (CLAD)<\/a><\/li>
  • Canine multi-focal retinopathy (CMR1\/2\/3)<\/a><\/li>
  • Canine multiple system degeneration (CMSD)<\/a><\/li>
  • Cardiomyopathy with juvenile mortality (CJM)<\/a><\/li>
  • Centronuclear myopathy (CNM)<\/a><\/li>
  • Cerebellar abiotrophy (CA)<\/a><\/li>
  • Cerebellar ataxia (CA1)<\/a><\/li>
  • Cerebellar ataxia* (CA)<\/a><\/li>
  • Cerebellar degeneration and myositis complex (CDMC)<\/a><\/li>
  • Cerebellar hypoplasia (CH)<\/a><\/li>
  • Cerebral dysfunction (CDFS)<\/a><\/li>
  • Charcot-Marie-Tooth neuropathy (CMT)<\/a><\/li>
  • Chondrodysplasia (dwarfism)<\/a><\/li>
  • Chondrodysplasia (CDPA) and -dystrophia (CDDY) (IVDD risk)<\/a><\/li>
  • Cleft lip\/palate and syndactyly (CLPS+CP1)<\/a><\/li>
  • CNS atrophy with cerebellar ataxia (CACA)<\/a><\/li>
  • Collie eye anomaly (CEA)<\/a><\/li>
  • Color dilution and neurological signs (CDN)<\/a><\/li>
  • Cone degeneration (CD)<\/a><\/li>
  • Congenital hypothyroidism with dwarfism (CH)<\/a><\/li>
  • Congenital hypothyroidism with goiter (CHG)<\/a><\/li>
  • Congenital ichthyosis<\/a><\/li>
  • Congenital idiopathic megaoesophagus (CIM)<\/a><\/li>
  • Congenital mirror movement disorder 1 (CMM1)<\/a><\/li>
  • Congenital myasthenic syndrome (CMS)<\/a><\/li>
  • Congenital stationary night blindness (CSNB)<\/a><\/li>
  • Copper storage disease - Copper toxicosis* (CT)<\/a><\/li>
  • Copper storage toxicosis (CT)<\/a><\/li>
  • Craniomandibular osteopathy (CMO)<\/a><\/li>
  • Cystinuria<\/a><\/li>
  • Dandy-Walker-like malformation (DWLM)<\/a><\/li>
  • Degenerative encephalopathy (DE)<\/a><\/li>
  • Degenerative myelopathy exon 1 (DM exon1)<\/a><\/li>
  • Degenerative myelopathy exon 2 (DM exon2)<\/a><\/li>
  • Degenerative myelopathy \u2013 risk modifier (DMRM)<\/a><\/li>
  • Delayed postoperative haemorrhage (DEPOH)<\/a><\/li>
  • Delayed postoperative haemorrhage (DEPOH)<\/a><\/li>
  • Dental-skeletal-retinal anomaly (DSRA)<\/a><\/li>
  • Dermatomyositis (DMS)<\/a><\/li>
  • Dermoid sinus (DS)<\/a><\/li>
  • Digital hyperkeratosis (DH\/HFH)<\/a><\/li>
  • Dilated cardiomyopathy (DCM)<\/a><\/li>
  • Dilated cardiomyopathy (DCM1-4)<\/a><\/li>
  • Dilated cardiomyopathy (DCM)<\/a><\/li>
  • Disproportionate dwarfism<\/a><\/li>
  • DLA typing (Dog leukocyte antigen)<\/a><\/li>
  • Dry eye curly coat syndrome (CCS)<\/a><\/li>
  • Dyserythropoietic anaemia and myopathy (DAMS)<\/a><\/li>
  • Dystrophic epidermolysis bullosa (DEB)<\/a><\/li>
  • Ectodermal dysplasia\/Skin fragility syndrome (ED\/SFS)<\/a><\/li>
  • Epidermolytic hyperkeratosis (EHK)<\/a><\/li>
  • Episodic falling (EF)<\/a><\/li>
  • Exercise induced collapse (EIC)<\/a><\/li>
  • Exfoliative cutaneous lupus erythematosus (ECLE)<\/a><\/li>
  • Factor VII deficiency<\/a><\/li>
  • Factor XI deficiency (F11)<\/a><\/li>
  • Familial Nephropathy (FN)<\/a><\/li>
  • Familial nephropathy (FN)<\/a><\/li>
  • Familial thyroid follicular cell carcinoma (FTFC) - risk analysis <\/a><\/li>
  • Fanconi syndrome<\/a><\/li>
  • Finnish Hound ataxia (FHA)<\/a><\/li>
  • Fucosidosis<\/a><\/li>
  • Gallbladder mucoceles (GBM)<\/a><\/li>
  • Glanzmann thrombasthenia (GT)<\/a><\/li>
  • Glaucoma and goniodysgenesis (GG)<\/a><\/li>
  • Globoid cell leucodystrophy (Krabbe disease)<\/a><\/li>
  • Glycogen storage disease (GSD-PGBM1)<\/a><\/li>
  • Glycogen storage disease GSD Ia<\/a><\/li>
  • Glycogen storage disease GSD II (Pompe disease)<\/a><\/li>
  • Glycogen storage disease GSD IIIa <\/a><\/li>
  • Gangliosidosis (GM1)<\/a><\/li>
  • GM2-Gangliosidosis (GM2)<\/a><\/li>
  • Grey Collie syndrome (Canine cyclic neutropenia) (GCS)<\/a><\/li>
  • Haemophilia A (factor VIII deficiency)<\/a><\/li>
  • Haemophilia A (factor VIII deficiency) (Havanese)<\/a><\/li>
  • Haemophilia B (factor IX deficiency)<\/a><\/li>
  • Haemorrhagic diathesis (Scott syndrome)<\/a><\/li>
  • Hair shaft dystrophy (HSD)<\/a><\/li>
  • Hereditary ataxia (HA)<\/a><\/li>
  • Hereditary cataract (HSF4)<\/a><\/li>
  • Hereditary cataract (HSF4)<\/a><\/li>
  • Hereditary deafness (DINGS1&2)<\/a><\/li>
  • Hereditary deafness (EOAD)<\/a><\/li>
  • Hereditary nasal parakeratosis (HNPK)<\/a><\/li>
  • Hereditary nasal parakeratosis (HNPK)<\/a><\/li>
  • Hereditary neuropathy (GHN)<\/a><\/li>
  • Hypertrophic cardiomyopathy (HCM)<\/a><\/li>
  • Hyperuricosuria (HUU\/SLC)<\/a><\/li>
  • Hypomyelination\/Shaking puppy syndrome (SPS)<\/a><\/li>
  • Hypophosphatasia (HPP)<\/a><\/li>
  • Ichthyosis<\/a><\/li>
  • Ichthyosis type 2<\/a><\/li>
  • Ichthyosis*<\/a><\/li>
  • Imerslund-Gr\u00e4sbeck syndrome (IGS)<\/a><\/li>
  • Inflammatory myopathy (IM)<\/a><\/li>
  • Inflammatory pulmonary disease (IPD)<\/a><\/li>
  • Intestinal Lipid Malabsorption (ILM)<\/a><\/li>
  • Junctional epidermolysis bullosa (JEB)<\/a><\/li>
  • Juvenile brain disease (JBD)<\/a><\/li>
  • Juvenile epilepsy (JE)<\/a><\/li>
  • Juvenile laryngeal paralysis & polyneuropathy (JLPP)<\/a><\/li>
  • Juvenile myoclonic epilepsy (JME)<\/a><\/li>
  • L-2-hydroxyglutaric aciduria (L-2-HGA)<\/a><\/li>
  • Lafora disease (EDTA blood only)<\/a><\/li>
  • Lagotto storage disease (LSD)<\/a><\/li>
  • Laryngeal paralysis with polyneuropathy type 3 (LPPN3)<\/a><\/li>
  • Laryngeal paralysis (LP)<\/a><\/li>
  • Late onset ataxia (LOA)<\/a><\/li>
  • Leonberger polyneuropathy 1 (LPN1)<\/a><\/li>
  • Leonberger polyneuropathy 2 (LPN2)<\/a><\/li>
  • Lethal acrodermatitis (LAD)<\/a><\/li>
  • Lethal lung disease (LAMP3) <\/a><\/li>
  • Leukocyte adhesion deficiency type III (LAD3)<\/a><\/li>
  • Leukoencephalomyelopathy (LEMP)<\/a><\/li>
  • Leukoencephalopathy (LEP)<\/a><\/li>
  • Limb-girdle muscular dystrophy (LGMD)<\/a><\/li>
  • Lundehund syndrome (LHS)<\/a><\/li>
  • Lysosomal storage disease (LSD)<\/a><\/li>
  • Macrothrombocytopenia (MTC)<\/a><\/li>
  • Macular corneal dystrophy (MCD)<\/a><\/li>
  • Malignant hyperthermia (MH)<\/a><\/li>
  • Maxillary canine tooth mesioversion (MCM)<\/a><\/li>
  • May-Hegglin anomaly (MHA)<\/a><\/li>
  • MCAD deficiency<\/a><\/li>
  • MDR1 gene variant (Ivermectin hypersensitivity)<\/a><\/li>
  • Methaemoglobinaemia (MetHg)<\/a><\/li>
  • Microphthalmia (RBP4)<\/a><\/li>
  • Mitochondrial fission encephalopathy (MFE)<\/a><\/li>
  • Mucopolysaccharidosis type IIIa (MPS3a)<\/a><\/li>
  • Mucopolysaccharidosis type IIIb (MPS3b)<\/a><\/li>
  • Mucopolysaccharidosis type VI (MPS6)<\/a><\/li>
  • Mucopolysaccharidosis type VII (MPS7)<\/a><\/li>
  • Multiocular defect (MOD)<\/a><\/li>
  • Muscular dystrophy (MD)<\/a><\/li>
  • Musladin-Lueke syndrome (MLS)<\/a><\/li>
  • Mycobacterium avium complex sensitivity (MAC)<\/a><\/li>
  • Myostatin mutation (\"bully\" gene)<\/a><\/li>
  • Myotonia congenita<\/a><\/li>
  • Myxomatous mitral valve disease (MMVD) <\/a><\/li>
  • Narcolepsy<\/a><\/li>
  • Necrotizing meningoencephalitis (NME\/PDE)<\/a><\/li>
  • Necrotizing myelopathy (ENM)<\/a><\/li>
  • Nemalin myopathy (NM)<\/a><\/li>
  • Neonatal cortical cerebellar abiotrophy (NCCD)<\/a><\/li>
  • Neonatal encephalopathy with seizures (NEWS)<\/a><\/li>
  • Neuroaxonal dystrophy (NAD)<\/a><\/li>
  • Neuronal ceroid lipofuscinosis (NCL)<\/a><\/li>
  • Neuronal ceroid lipofuscinosis (NCL)<\/a><\/li>
  • Neuronal ceroid lipofuscinosis (NCL) <\/a><\/li>
  • Obesity<\/a><\/li>
  • Osteochondrodysplasia (OCD)<\/a><\/li>
  • Osteogenesis imperfecta (brittle bone disease)<\/a><\/li>
  • Paradoxical pseudomyotonia (PP)<\/a><\/li>
  • Paroxysmal dyskinesia (PxD)<\/a><\/li>
  • Paroxysmal exercise-induced dyskinesia (PED)<\/a><\/li>
  • Persistent M\u00fcllerian duct syndrome (PMDS)<\/a><\/li>
  • Phosphofructokinase deficiency (PFKD)<\/a><\/li>
  • Pituitary dwarfism<\/a><\/li>
  • Polioencephalopathy (PE)<\/a><\/li>
  • Polycystic kidney disease (PKD)<\/a><\/li>
  • Postoperative haemorrhage (P2Y12)<\/a><\/li>
  • Prekallikrein deficiency (KLK)<\/a><\/li>
  • Primary ciliary dyskinesia (PCD)<\/a><\/li>
  • Primary hyperoxaluria (PH)<\/a><\/li>
  • Primary hyperparathyroidism (PHPT)<\/a><\/li>
  • Primary immunodeficiency type 2 (PIPS2)<\/a><\/li>
  • Primary lens luxation (PLL)<\/a><\/li>
  • Primary open angle glaucoma (POAG)<\/a><\/li>
  • Primary open angle glaucoma and lens luxation (POAG\/PLL)<\/a><\/li>
  • Progressive retinal atrophy (BBS4-PRA) <\/a><\/li>
  • Progressive retinal atrophy (Bas-PRA1)<\/a><\/li>
  • Progressive retinal atrophy (BBS2-PRA)<\/a><\/li>
  • Progressive retinal atrophy (CNGA1-PRA)<\/a><\/li>
  • Progressive retinal atrophy (cord1\/crd4-PRA)<\/a><\/li>
  • Progressive retinal atrophy (crd-PRA)<\/a><\/li>
  • Progressive retinal atrophy (crd1-PRA)<\/a><\/li>
  • Progressive retinal atrophy (crd2-PRA)<\/a><\/li>
  • Progressive retinal atrophy (crd3-PRA)<\/a><\/li>
  • Progressive retinal atrophy (dominant PRA)<\/a><\/li>
  • Progressive retinal atrophy (early-onset, eo-PRA)<\/a><\/li>
  • Progressive retinal atrophy (g-PRA)<\/a><\/li>
  • Progressive retinal atrophy (GR-PRA1)<\/a><\/li>
  • Progressive retinal atrophy (GR-PRA2)<\/a><\/li>
  • Progressive retinal atrophy (GTPBP2-PRA)<\/a><\/li>
  • Progressive retinal atrophy (GUCY2D-PRA)<\/a><\/li>
  • Progressive retinal atrophy (IFT122-PRA)<\/a><\/li>
  • Progressive retinal atrophy (JPH2-PRA)<\/a><\/li>
  • Progressive retinal atrophy (MERTK-PRA)<\/a><\/li>
  • Progressive retinal atrophy (NECAP1-PRA)<\/a><\/li>
  • Progressive retinal atrophy (pap-PRA1)<\/a><\/li>
  • Progressive retinal atrophy (PRA3)<\/a><\/li>
  • Progressive retinal atrophy (PRA4)<\/a><\/li>
  • Progressive retinal atrophy (prcd-PRA)<\/a><\/li>
  • Progressive retinal atrophy (rcd1-PRA)<\/a><\/li>
  • Progressive retinal atrophy (rcd1a-PRA)<\/a><\/li>
  • Progressive retinal atrophy (rcd2-PRA)<\/a><\/li>
  • Progressive retinal atrophy (rcd3-PRA)<\/a><\/li>
  • Progressive retinal atrophy (rcd4-PRA)<\/a><\/li>
  • Progressive retinal atrophy (Type B1-PRA, HIVEP3)<\/a><\/li>
  • Progressive retinal atrophy (XL-PRA)<\/a><\/li>
  • Progressive retinal atrophy with neurodegeneration (PCYT2 deficiency)<\/a><\/li>
  • Protein losing nephropathy (PLN)<\/a><\/li>
  • Pyruvate dehydrogenase phosphatase 1 deficiency (PDP1)<\/a><\/li>
  • Pyruvate kinase deficiency (PK)<\/a><\/li>
  • Raine syndrome<\/a><\/li>
  • Renal cystadenocarcinoma and nodular fibrosis (RCND)<\/a><\/li>
  • Renal dysplasia and hepatic fibrosis (RDHN)<\/a><\/li>
  • Retinal dysplasia (OSD)<\/a><\/li>
  • Retinal dysplasia (OSD)<\/a><\/li>
  • Ridge<\/a><\/li>
  • Robinow-like syndrome (DVL2)<\/a><\/li>
  • Sensory neuropathy (SN)<\/a><\/li>
  • Severe combined immuno deficiency (SCID)<\/a><\/li>
  • Shar Pei autoinflammatory disease* (SPAID)<\/a><\/li>
  • Skeletal dysplasia 2 (dwarfism) (SD2)<\/a><\/li>
  • Spinal dysraphism (NTD)<\/a><\/li>
  • Spinocerebellar ataxia (SCA)<\/a><\/li>
  • Spondylocostal dysostosis (Comma defect)<\/a><\/li>
  • Spongiforme leukoencephalomyelopathy* (SLEM)<\/a><\/li>
  • Spongy degeneration with cerebellar ataxia type 1 (SDCA1)<\/a><\/li>
  • Spongy degeneration with cerebellar ataxia type 2 (SDCA2)<\/a><\/li>
  • Squamous cell carcinoma of the toe - risk analysis<\/a><\/li>
  • Stargardt disease (STGD, retinal degeneration)<\/a><\/li>
  • Startle disease<\/a><\/li>
  • Subacute necrotising encephalopathy (SNE)<\/a><\/li>
  • Succinic semialdehyde dehydrogenase deficiency (SSADHD)<\/a><\/li>
  • Thrombopathia<\/a><\/li>
  • Trapped neutrophil syndrome (TNS)<\/a><\/li>
  • Upper airway syndrome (UAS)<\/a><\/li>
  • van den Ende-Gupta syndrome (VDEGS)<\/a><\/li>
  • Ventricular arrhythmia (IVA)<\/a><\/li>
  • Vitamin D dependent rickets (VDR)<\/a><\/li>
  • von Willebrand disease type 1 (vWD1)<\/a><\/li>
  • von Willebrand disease type 2 (vWD2)<\/a><\/li>
  • von Willebrand disease type 3 (vWD3)<\/a><\/li>
  • Warburg micro syndrome 1 (WARBM1)<\/a><\/li>
  • X-chromosomal severe immunodeficiency (X-SCID)<\/a><\/li>
  • X-linked myopathy (XL-MTM)<\/a><\/li>
  • X-linked retinal dysplasia (XLRD)<\/a><\/li>
  • Xanthinuria type II<\/a><\/li><\/div><\/div>\n

     <\/p>\n

    * partner laboratory[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

    [vc_row][vc_column][vc_column_text]For some breeds, we also offer breed-specific genetic test combinations to test for several hereditary diseases.[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=”vc_default” css=”.vc_custom_1612193220488{margin-top: 30px !important;}”][vc_column][vc_column_text]   * partner laboratory[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1210000,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1211000","page","type-page","status-publish","hentry","description-off"],"_links":{"self":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1211000","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/comments?post=1211000"}],"version-history":[{"count":0,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1211000\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/pages\/1210000"}],"wp:attachment":[{"href":"https:\/\/laboklin.com\/en\/wp-json\/wp\/v2\/media?parent=1211000"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}